BetterLife Pharma Inc. (BETR)
CSE
Closed
Aug 21, 2026
Day's Range
0.300052 wk Range
0.0400Overview - BETR - BetterLife Pharma Inc.
Key Statistics
Valuation
Enterprise Value
56.83M
P/E (Trailing)
‪-32.49‬
Price / Book
‪-7.80‬
EV / EBITDA
‪-30.89‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-500.55%‬
Return on Equity
‪23.05%‬
Ownership
Shares Outstanding
161.78M
Float
106.70M
Short % of Shares Outstanding
‪0.05%‬
Held by Insiders
‪32.49%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪0.2092‬
200-Day Avg
‪0.0963‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - BETR - BetterLife Pharma Inc.
Peer Comparison
Compared with companies in Biotechnology listed on CSE.
Profile Summary - BETR - BetterLife Pharma Inc.
About
BetterLife Pharma Inc. is an emerging biotechnology company focused on developing cutting-edge treatments for mental health disorders, primarily through psychedelic compounds. The company's work is centered on harnessing the therapeutic potential of psychedelic derivatives, aiming to address unmet needs in mental…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
